Ectopic Pregnancy: Diagnosis, Methotrexate Criteria & Surgery

Q: How do you differentiate an ectopic pregnancy from a normal intrauterine pregnancy that is too early to see on ultrasound?

Serial β-hCG monitoring: normal IUP in the first trimester doubles every ~48h (minimum 53% rise). Ectopic or failing pregnancies show a plateau or rise 25 ng/mL suggests viable IUP; <5 ng/mL suggests non-viable pregnancy (ectopic or failing IUP).

Q: Can a patient with an ectopic pregnancy have a negative urine pregnancy test?

Standard urine hCG tests turn positive at β-hCG ~20–25 mIU/mL. Very early ectopic pregnancies may be below this threshold, producing a false-negative urine test. If clinical suspicion is high (pelvic pain, vaginal bleeding, amenorrhea, risk factors), a quantitative serum β-hCG should be ordered regardless of the urine test result — it is more sensitive. Never exclude ectopic solely on a negative urine pregnancy test.

The 60-second version

Classic triad: amenorrhea + vaginal bleeding + unilateral pelvic pain; prior ectopic pregnancy and PID are top risk factors
β-hCG discriminatory zone (~1500–2000): empty uterus on TVUS above this threshold = ectopic until proven otherwise
Normal IUP: β-hCG rises ≥53% in 48h; ectopic or failing pregnancy: plateau or suboptimal rise
Methotrexate criteria: hemodynamically stable, ≤3.5 cm mass, no fetal cardiac activity, β-hCG <5000, no contraindications
Ruptured ectopic = surgical emergency; all Rh-negative patients receive RhoGAM regardless of management approach

Risk Factors, Diagnosis, and the Discriminatory Zone

**Risk factors** (anything that impairs tubal motility or anatomy): prior ectopic pregnancy (most significant risk factor, 10–25% recurrence), pelvic inflammatory disease (PID) / salpingitis (especially Chlamydia trachomatis — tubal scarring), prior tubal surgery (salpingotomy, tubal ligation — sterilization failure has 50% ectopic rate), intrauterine device (IUD protects against intrauterine pregnancy but not ectopic — if pregnancy occurs with IUD in place, high ectopic risk), in vitro fertilization (IVF), endometriosis, smoking. **Presentation**: amenorrhea + vaginal bleeding + unilateral pelvic/adnexal pain. Rupture: sudden severe pain, peritoneal signs, hemodynamic instability (orthostatic hypotension, syncope). **β-hCG discriminatory zone**: threshold (typically 1500–2000 mIU/mL) at which a normal intrauterine pregnancy should be visible on transvaginal ultrasound (TVUS). If β-hCG ≥ discriminatory zone and no IUP on TVUS → ectopic or failed IUP (requires management). β-hCG doubling time: normal IUP doubles every 48h (at minimum 53% rise in 48h); ectopic or failing pregnancy → suboptimal rise or plateau. An empty uterus on TVUS + β-hCG above discriminatory zone = ectopic until proven otherwise.

Surgical vs. Medical Management

**Ruptured ectopic = surgical emergency**: any signs of rupture (hemodynamic instability, peritoneal signs, hemoperitoneum on ultrasound) → immediate surgical intervention, type and crossmatch, IV access. Surgical approach: laparoscopic salpingectomy (remove entire tube — preferred) vs salpingostomy (incise tube, remove ectopic, preserve tube — only if other tube damaged and future fertility critical, higher persistent trophoblast rate). **Methotrexate criteria** (medical management, inhibits rapidly dividing cells via folate antagonism): patient is hemodynamically stable, compliant, with close follow-up available; ectopic mass ≤3.5 cm; no fetal cardiac activity; β-hCG <5,000 mIU/mL (some protocols use <10,000); no contraindications (liver disease, immunodeficiency, active lung disease, blood dyscrasias, breastfeeding, renal insufficiency). **Single-dose MTX protocol**: MTX 50 mg/m² IM; check β-hCG on days 4 and 7; if decline <15% → second dose. Follow β-hCG weekly to zero. **Expectant management**: selected cases with very low β-hCG (<200), declining levels, no significant adnexal mass, minimal symptoms — high monitoring required. **Rh status**: all Rh-negative patients with ectopic pregnancy receive Rho(D) immune globulin (RhoGAM) to prevent sensitization.

Post-treatment Follow-up and Complications

**Post-methotrexate monitoring**: β-hCG should decline ≥15% between days 4 and 7 after injection. Transient rise in β-hCG days 1–3 is normal ('MTX surge') — do not repeat treatment based on this. Persistent elevation or inadequate decline = treatment failure → repeat MTX or surgery. Separation pain (days 3–7): mild cramping is common as ectopic tissue separates; distinguish from rupture (sudden severe pain + hemodynamic instability → surgical). Advise: no intercourse, no NSAIDs (reduce methotrexate clearance and mask pain), no folic acid supplements, no alcohol during treatment, avoid sun exposure (MTX photosensitivity), confirm resolution before attempting another pregnancy. **Fertility counseling**: after salpingectomy, contralateral tube must be functional for future pregnancy; 60–70% of women achieve intrauterine pregnancy after ectopic. After medical management, risk of recurrent ectopic is similar to surgical. **Heterotopic pregnancy** (simultaneous intrauterine + ectopic): rare (<1:10,000 spontaneous; 1:100 with IVF); cannot use β-hCG to monitor (IUP also produces hCG); requires surgical management of ectopic while preserving IUP.

Test yourself

Quick check — 3 questions

1. A 28-year-old woman with a history of chlamydial PID presents with 6 weeks of amenorrhea, vaginal spotting, and right lower quadrant pain. Urine pregnancy test is positive. Transvaginal ultrasound shows no intrauterine gestational sac and a 2.8 cm right adnexal mass. Serum β-hCG is 3,200 mIU/mL. She is hemodynamically stable with no peritoneal signs. What is the most appropriate management?

2. A 32-year-old woman treated with methotrexate 4 days ago for an ectopic pregnancy calls reporting increased abdominal pain. Her β-hCG today is 2,800 (was 2,600 on day of treatment). She is hemodynamically stable with no peritoneal signs. What is the most appropriate response?

3. A 25-year-old Rh-negative woman undergoes laparoscopic salpingectomy for a ruptured right ectopic pregnancy. What additional intervention is required before discharge?

Frequently asked questions

How do you differentiate an ectopic pregnancy from a normal intrauterine pregnancy that is too early to see on ultrasound?

Serial β-hCG monitoring: normal IUP in the first trimester doubles every ~48h (minimum 53% rise). Ectopic or failing pregnancies show a plateau or rise <53% in 48h. At β-hCG ≥1500–2000 (discriminatory zone), a normal IUP should be visible as a gestational sac on transvaginal ultrasound. Absence of IUP at this threshold strongly suggests ectopic. Progesterone level: >25 ng/mL suggests viable IUP; <5 ng/mL suggests non-viable pregnancy (ectopic or failing IUP).

Can a patient with an ectopic pregnancy have a negative urine pregnancy test?

Standard urine hCG tests turn positive at β-hCG ~20–25 mIU/mL. Very early ectopic pregnancies may be below this threshold, producing a false-negative urine test. If clinical suspicion is high (pelvic pain, vaginal bleeding, amenorrhea, risk factors), a quantitative serum β-hCG should be ordered regardless of the urine test result — it is more sensitive. Never exclude ectopic solely on a negative urine pregnancy test.

Practice makes permanent

Lock this into long-term memory

Progress Note's adaptive engine spaces your reviews automatically — so this stays with you through boards and onto the wards.

Start practicing free

Share Post LinkedIn Reddit

Continue the curriculum

Preeclampsia: Diagnosis, Severe Features, and Management

Neonatal Jaundice: Physiologic vs Pathologic and Phototherapy

Acute Kidney Injury: Prerenal, Intrinsic, and Postrenal